CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Treasury Stock	Accumulated Other Comprehensive Income (Loss)	Retained Earnings
Beginning balance (in shares) at Dec. 31, 2023		103,405
Beginning balance at Dec. 31, 2023	$ 506,705	$ 133	$ 738,515	$ (635,078)	$ 609	$ 402,526
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under incentive award plan (in shares)		786
Issuance of common stock under incentive award plan	3,485		3,485
Shares tendered to satisfy cost and statutory withholding requirements for net settlement of cashless option exercises and vesting of restricted stock (in shares)		(143)
Shares tendered to satisfy cost and statutory withholding requirements for net settlement of cashless option exercises and vesting of restricted stock	(3,554)		2,032	(5,586)
Repurchase of common stock in connection with Stock Repurchase Program (in shares)		(20)
Repurchase of common stock in connection with Stock Repurchase Program	(476)			(476)
Excise tax related to net share repurchases	81			81
Stock-based compensation	12,929		12,929
Vesting of RSAs in connection with ESPP	1,283		1,283
Other comprehensive income (loss), net of tax	(351)				(351)
Net income	27,762					27,762
Ending balance (in shares) at Mar. 31, 2024		104,028
Ending balance at Mar. 31, 2024	547,864	$ 133	758,244	(641,059)	258	430,288
Beginning balance (in shares) at Dec. 31, 2023		103,405
Beginning balance at Dec. 31, 2023	506,705	$ 133	738,515	(635,078)	609	402,526
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	110,463
Ending balance (in shares) at Sep. 30, 2024		104,703
Ending balance at Sep. 30, 2024	638,835	$ 135	806,317	(682,177)	1,571	512,989
Beginning balance (in shares) at Mar. 31, 2024		104,028
Beginning balance at Mar. 31, 2024	547,864	$ 133	758,244	(641,059)	258	430,288
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under incentive award plan (in shares)		700
Issuance of common stock under incentive award plan	7,574	$ 1	7,573
Shares tendered to satisfy cost and statutory withholding requirements for net settlement of cashless option exercises and vesting of restricted stock (in shares)		(208)
Shares tendered to satisfy cost and statutory withholding requirements for net settlement of cashless option exercises and vesting of restricted stock	(6,242)			(6,242)
Repurchase of common stock in connection with Stock Repurchase Program (in shares)		(122)
Repurchase of common stock in connection with Stock Repurchase Program	(3,478)			(3,478)
Excise tax related to net share repurchases	16			16
Stock-based compensation	13,881		13,881
Vesting of RSAs in connection with ESPP	1,314		1,314
Other comprehensive income (loss), net of tax	(174)
Net income	35,488					35,488
Ending balance (in shares) at Jun. 30, 2024		104,398
Ending balance at Jun. 30, 2024	596,243	$ 134	781,012	(650,763)	84	465,776
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under incentive award plan (in shares)		1,175
Issuance of common stock under incentive award plan	10,322	$ 1	10,321
Shares tendered to satisfy cost and statutory withholding requirements for net settlement of cashless option exercises and vesting of restricted stock (in shares)		(526)
Shares tendered to satisfy cost and statutory withholding requirements for net settlement of cashless option exercises and vesting of restricted stock	(19,704)			(19,704)
Repurchase of common stock in connection with Stock Repurchase Program (in shares)		(344)
Repurchase of common stock in connection with Stock Repurchase Program	(11,710)			(11,710)
Stock-based compensation	14,286		14,286
Vesting of RSAs in connection with ESPP	698		698
Other comprehensive income (loss), net of tax	1,487
Net income	47,213					47,213
Ending balance (in shares) at Sep. 30, 2024		104,703
Ending balance at Sep. 30, 2024	638,835	$ 135	806,317	(682,177)	1,571	512,989
Beginning balance (in shares) at Dec. 31, 2024		105,113
Beginning balance at Dec. 31, 2024	679,589	$ 136	832,108	(696,173)	(217)	543,735
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under incentive award plan (in shares)		1,712
Issuance of common stock under incentive award plan	12,900	$ 1	12,899
Shares tendered to satisfy cost and statutory withholding requirements for net settlement of cashless option exercises and vesting of restricted stock (in shares)		(341)
Shares tendered to satisfy cost and statutory withholding requirements for net settlement of cashless option exercises and vesting of restricted stock	(21,086)			(21,086)
Repurchase of common stock in connection with Stock Repurchase Program (in shares)		(500)
Repurchase of common stock in connection with Stock Repurchase Program	(27,433)			(27,433)
Stock-based compensation	15,687		15,687
Vesting of RSAs in connection with ESPP	2,172		2,172
Other comprehensive income (loss), net of tax	909				909
Net income	20,547					20,547
Ending balance (in shares) at Mar. 31, 2025		105,984
Ending balance at Mar. 31, 2025	683,285	$ 137	862,866	(744,692)	692	564,282
Beginning balance (in shares) at Dec. 31, 2024		105,113
Beginning balance at Dec. 31, 2024	679,589	$ 136	832,108	(696,173)	(217)	543,735
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	75,364
Ending balance (in shares) at Sep. 30, 2025		105,124
Ending balance at Sep. 30, 2025	631,902	$ 139	933,613	(923,290)	2,341	619,099
Beginning balance (in shares) at Mar. 31, 2025		105,984
Beginning balance at Mar. 31, 2025	683,285	$ 137	862,866	(744,692)	692	564,282
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under incentive award plan (in shares)		1,048
Issuance of common stock under incentive award plan	15,123	$ 1	15,122
Shares tendered to satisfy cost and statutory withholding requirements for net settlement of cashless option exercises and vesting of restricted stock (in shares)		(262)
Shares tendered to satisfy cost and statutory withholding requirements for net settlement of cashless option exercises and vesting of restricted stock	(19,221)			(19,221)
Repurchase of common stock in connection with Stock Repurchase Program (in shares)		(1,482)
Repurchase of common stock in connection with Stock Repurchase Program	(103,018)			(103,018)
Stock-based compensation	19,427		19,427
Vesting of RSAs in connection with ESPP	3,449		3,449
Other comprehensive income (loss), net of tax	1,599				1,599
Net income	35,149					35,149
Ending balance (in shares) at Jun. 30, 2025		105,288
Ending balance at Jun. 30, 2025	635,793	$ 138	900,864	(866,931)	2,291	599,431
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under incentive award plan (in shares)		640
Issuance of common stock under incentive award plan	9,944	$ 1	9,943
Shares tendered to satisfy cost and statutory withholding requirements for net settlement of cashless option exercises and vesting of restricted stock (in shares)		(194)
Shares tendered to satisfy cost and statutory withholding requirements for net settlement of cashless option exercises and vesting of restricted stock	(13,895)			(13,895)
Repurchase of common stock in connection with Stock Repurchase Program (in shares)		(610)
Repurchase of common stock in connection with Stock Repurchase Program	(42,464)			(42,464)
Stock-based compensation	20,386		20,386
Vesting of RSAs in connection with ESPP	2,420		2,420
Other comprehensive income (loss), net of tax	50				50
Net income	19,668					19,668
Ending balance (in shares) at Sep. 30, 2025		105,124
Ending balance at Sep. 30, 2025	$ 631,902	$ 139	$ 933,613	$ (923,290)	$ 2,341	$ 619,099